<?xml version="1.0" encoding="utf-8"?>
<!DOCTYPE trials [
<!ELEMENT trials (trial+)>

<!ELEMENT trial (main,contacts,countries,criteria,health_condition_code,health_condition_keyword,intervention_code,
          intervention_keyword,primary_outcome,secondary_outcome,secondary_sponsor,secondary_ids,source_support,ethics_reviews)>

<!ELEMENT main (trial_id,utrn?,reg_name,date_registration,primary_sponsor,public_title,acronym?,scientific_title,scientific_acronym?,
          date_enrolment,type_enrolment,target_size,recruitment_status,url?,study_type,study_design,phase,hc_freetext?,i_freetext?,results_actual_enrolment,results_date_completed,results_url_link,results_summary,           results_date_posted,results_date_first_publication,results_baseline_char,results_participant_flow,results_adverse_events,results_outcome_measures,results_url_protocol,results_IPD_plan, results_IPD_description)>
<!ELEMENT trial_id (#PCDATA)>
<!ELEMENT utrn (#PCDATA)>
<!ELEMENT reg_name (#PCDATA)>
<!ELEMENT date_registration (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT primary_sponsor (#PCDATA)>
<!ELEMENT public_title (#PCDATA)>
<!ELEMENT acronym (#PCDATA)>
<!ELEMENT scientific_title (#PCDATA)>
<!ELEMENT scientific_acronym (#PCDATA)>
<!ELEMENT date_enrolment (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT type_enrolment (#PCDATA)>
<!ELEMENT target_size (#PCDATA)>
<!ELEMENT recruitment_status (#PCDATA)><!-- Pending,Recruiting,Suspended,Complete,Other -->
<!ELEMENT url (#PCDATA)>
<!ELEMENT study_type (#PCDATA)><!-- interventional,observational -->
<!ELEMENT study_design (#PCDATA)>
<!ELEMENT phase (#PCDATA)>
<!ELEMENT hc_freetext (#PCDATA)>
<!ELEMENT i_freetext (#PCDATA)>
<!ELEMENT results_actual_enrolment (#PCDATA)>
<!ELEMENT results_date_completed (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_url_link (#PCDATA)>
<!ELEMENT results_summary (#PCDATA)>
<!ELEMENT results_date_posted (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_date_first_publication (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT results_baseline_char (#PCDATA)>
<!ELEMENT results_participant_flow (#PCDATA)>
<!ELEMENT results_adverse_events (#PCDATA)>
<!ELEMENT results_outcome_measures (#PCDATA)>
<!ELEMENT results_url_protocol (#PCDATA)>
<!ELEMENT results_IPD_plan (#PCDATA)>
<!ELEMENT results_IPD_description (#PCDATA)>


<!ELEMENT contacts (contact+)>
<!ELEMENT contact (type,firstname,middlename,lastname,address,city,country1,zip,telephone,email,affiliation)>
<!ELEMENT type (#PCDATA)><!-- Public,Scientific -->
<!ELEMENT firstname (#PCDATA)>
<!ELEMENT middlename (#PCDATA)>
<!ELEMENT lastname (#PCDATA)>
<!ELEMENT address (#PCDATA)>
<!ELEMENT city (#PCDATA)>
<!ELEMENT country1 (#PCDATA)>
<!ELEMENT zip (#PCDATA)>
<!ELEMENT telephone (#PCDATA)>
<!ELEMENT email (#PCDATA)>
<!ELEMENT affiliation (#PCDATA)>

<!ELEMENT countries (country2+)>
<!ELEMENT country2 (#PCDATA)>

<!ELEMENT criteria (inclusion_criteria,agemin,agemax,gender,exclusion_criteria)>
<!ELEMENT inclusion_criteria (#PCDATA)>
<!ELEMENT agemin (#PCDATA)>
<!ELEMENT agemax (#PCDATA)>
<!ELEMENT gender (#PCDATA)>
<!ELEMENT exclusion_criteria (#PCDATA)>

<!ELEMENT health_condition_code (hc_code+)>
<!ELEMENT hc_code (#PCDATA)>

<!ELEMENT health_condition_keyword (hc_keyword+)>
<!ELEMENT hc_keyword (#PCDATA)>

<!ELEMENT intervention_code (i_code+)>
<!ELEMENT i_code (#PCDATA)>

<!ELEMENT intervention_keyword (i_keyword+)>
<!ELEMENT i_keyword (#PCDATA)>

<!ELEMENT primary_outcome (prim_outcome+)>
<!ELEMENT prim_outcome (#PCDATA)>

<!ELEMENT secondary_outcome (sec_outcome+)>
<!ELEMENT sec_outcome (#PCDATA)>

<!ELEMENT secondary_sponsor (sponsor_name+)>
<!ELEMENT sponsor_name (#PCDATA)>

<!ELEMENT secondary_ids (secondary_id+)>
<!ELEMENT secondary_id (sec_id,issuing_authority)>
<!ELEMENT sec_id (#PCDATA)>
<!ELEMENT issuing_authority (#PCDATA)>

<!ELEMENT source_support (source_name+)>
<!ELEMENT source_name (#PCDATA)>

<!ELEMENT ethics_reviews (ethics_review+)>
<!ELEMENT ethics_review (status,approval_date,contact_name,contact_address,contact_phone,contact_email)>
<!ELEMENT status (#PCDATA)><!-- Not approved,Approved,NA -->
<!ELEMENT approval_date (#PCDATA)><!-- dd/mm/yyyy -->
<!ELEMENT contact_name (#PCDATA)>
<!ELEMENT contact_address (#PCDATA)>
<!ELEMENT contact_phone (#PCDATA)>
<!ELEMENT contact_email (#PCDATA)>
]>
<trials>
  <trial>
    <main>
      <trial_id>IRCT20200711048079N1</trial_id>
      <utrn></utrn>
      <reg_name>IRCT</reg_name>
      <date_registration>2020-08-01</date_registration>
      <primary_sponsor>Shahid Beheshti University of Medical Sciences</primary_sponsor>
      <public_title>The Comparison of Three Methods of Eye Care Using Polyethylene Covers, Artificial Tear Gel and Common Method on Prevention of Dry Eye and Corneal Ulcer in Older People Admitted to Intensive Care Units</public_title>
      <acronym></acronym>
      <scientific_title>The Comparison of Three Methods of Eye Care Using Polyethylene Covers, Artificial Tear Gel and Common Method on Prevention of Dry Eye and Corneal Ulcer in Older People Admitted to Intensive Care Units</scientific_title>
      <scientific_acronym></scientific_acronym>
      <date_enrolment>2020-08-22</date_enrolment>
      <type_enrolment>anticipated</type_enrolment>
      <target_size>99</target_size>
      <recruitment_status>Complete</recruitment_status>
      <url>https://irct.ir/trial/49563</url>
      <study_type>interventional</study_type>
      <study_design>Randomization: Randomized, Blinding: Single blinded, Placebo: Not used, Assignment: Parallel, Purpose: Prevention, Randomization description: In this study, the available random sampling method will be used and participants in the study are divided into three groups A, B and C, which group A artificial tear gels in the right eye and in the left eye polyethylene Covers, in Group B, artificial tear gels in the left eye and polyethylene Covers in the right eye and Group C, is the usual method. Intervention methods for random assignment will be placed in dark envelopes and each participant will be assigned an envelope using a random number table. The allocation of the number of study participants to each hospital will be based on the number of annual hospitalizations in the intensive care unit of that center, Blinding description: Due to the patient's condition, which has a decreased level of consciousness, is under mechanical ventilation, and receives sedatives and muscle relaxants, the patient is not aware of the type of intervention, but to any of the participants' legal guardians if they wish to participate in the project, Explanations about the purpose of the research and ensuring the confidentiality of data information and informed consent will be obtained.</study_design>
      <phase>3</phase>
      <hc_freetext>Condition 1: Dry Eye Syndrome. Condition 2: Corneal Ulcer.</hc_freetext>
      <i_freetext>Intervention 1: Intervention group: Group A:  Artificial tear gels in the right eye every six hours for five days and in the left eye polyethylene coating and its replacement every 12 hours for five days. Intervention 2: Intervention group: Group B: Artificial tear gels in the left eye every six hours for five days and in the right eye polyethylene coating and its replacement every 12 hours for five days. Intervention 3: Intervention group: Group C: Both eyes of the patient are cared for in the usual way, so that both eyes are covered with anti-allergy glue and change the glue every 12 hours for five days.</i_freetext>
      <results_actual_enrolment></results_actual_enrolment>
      <results_date_completed></results_date_completed>
      <results_url_link></results_url_link>
      <results_summary></results_summary>
      <results_date_posted></results_date_posted>
      <results_date_first_publication></results_date_first_publication>
      <results_baseline_char></results_baseline_char>
      <results_participant_flow></results_participant_flow>
      <results_adverse_events></results_adverse_events>
      <results_outcome_measures></results_outcome_measures>
      <results_url_protocol></results_url_protocol>
      <results_IPD_plan>Undecided - It is not yet known if there will be a plan to make this available</results_IPD_plan>
      <results_IPD_description>Justification or reason for indecision in sharing IPD is There is no more information.</results_IPD_description>
    </main>
    <contacts>
      <contact>
        <type>public</type>
        <firstname>Ali Darvishpoor Kakhki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Internal Surgery, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences,  Niayesh Highway Intersection, Valiasr St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>Ali.darvishpoor@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
      <contact>
        <type>scientific</type>
        <firstname>Ali Darvishpoor Kakhki</firstname>
        <middlename></middlename>
        <lastname></lastname>
        <address>Department of Internal Surgery, School of Nursing and Midwifery, Shahid Beheshti University of Medical Sciences,  Niayesh Highway Intersection, Valiasr St.</address>
        <city>Tehran</city>
        <country1>Iran (Islamic Republic of)</country1>
        <zip>1985717443</zip>
        <telephone>+98 21 8865 5366</telephone>
        <email>Ali.darvishpoor@yahoo.com</email>
        <affiliation>Shahid Beheshti University of Medical Sciences</affiliation>
      </contact>
    </contacts>
    <countries>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
      <country2>Iran (Islamic Republic of)</country2>
    </countries>
    <criteria>
      <inclusion_criteria>They are 60 years old or older.
Be hospitalized in the intensive care unit.
Have a endotracheal tube and be mechanically ventilated.
Have a Glasgow coma scale score of seven or below seven.
Their body temperature should be between 36.4 to 37.2 in the morning and 37.2 to 37.8 in the evening using an oral thermometer.
Do not have dry eyes at the time of admission using the Schirmer test.
Do not have corneal ulcers at the time of admission using the Fluorescein test.
Blink less than five times per minute.
No head and face trauma.
Have no signs of increased intracranial pressure.
Have no history of using eye lubricants (before hospitalization).
Have no history of eye disease or eye surgery.
Have no history of hospitalization in the intensive care unit during the past month.
Incomplete closing of the eyelids due to the use of sedatives
There are no wounds, eye injuries or eye infections</inclusion_criteria>
      <agemin>60 years</agemin>
      <agemax>no limit</agemax>
      <gender>Both</gender>
      <exclusion_criteria>Patients whose hospitalization time is more than 24 hours.
Patients admitted to the ward with a diagnosis of brain death.
Patients whose level of consciousness is increased and they are separated from mechanical ventilation
Patients' deaths occur.
Patients who are admitted to the intensive care unit for less than five days.
Patients who are transferred to other wards during the study.
Patients whose blinking reflex returns.
Patients who are allergic to artificial tears gel.</exclusion_criteria>
    </criteria>
    <health_condition_code>
      <hc_code>H04.12</hc_code>
      <hc_code>H16.0</hc_code>
    </health_condition_code>
    <health_condition_keyword>
      <hc_keyword>Dry eye syndrome</hc_keyword>
      <hc_keyword>Corneal ulcer</hc_keyword>
    </health_condition_keyword>
    <intervention_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
      <i_code>Prevention</i_code>
    </intervention_code>
    <intervention_keyword>
      <i_keyword>Intervention group: Group A:  Artificial tear gels in the right eye every six hours for five days and in the left eye polyethylene coating and its replacement every 12 hours for five days.</i_keyword>
      <i_keyword>Intervention group: Group B: Artificial tear gels in the left eye every six hours for five days and in the right eye polyethylene coating and its replacement every 12 hours for five days.</i_keyword>
      <i_keyword>Intervention group: Group C: Both eyes of the patient are cared for in the usual way, so that both eyes are covered with anti-allergy glue and change the glue every 12 hours for five days.</i_keyword>
    </intervention_keyword>
    <primary_outcome>
      <prim_outcome>Dry eye. Timepoint: The first day of intervention and then daily for five days. Method of measurement: Schirmer Test.</prim_outcome>
      <prim_outcome>Corneal Ulcer. Timepoint: The first day of intervention and then daily for five days. Method of measurement: Fluorescein Test.</prim_outcome>
    </primary_outcome>
    <secondary_outcome>
      <sec_outcome></sec_outcome>
    </secondary_outcome>
    <secondary_sponsor>
      <sponsor_name></sponsor_name>
    </secondary_sponsor>
    <secondary_ids>
      <secondary_id>
        <sec_id></sec_id>
        <issuing_authority></issuing_authority>
      </secondary_id>
    </secondary_ids>
    <source_support>
      <source_name>Shahid Beheshti University of Medical Sciences</source_name>
    </source_support>
    <ethics_reviews>
      <ethics_review>
        <status>Approved</status>
        <approval_date>2020-07-26</approval_date>
        <contact_name>Ethics committee of School of Pharmacy, Nursing and Midwifery, Shahid Beheshti University of Medical</contact_name>
        <contact_address>School of Pharmacy, Nursing and Midwifery, Shahid Beheshti University of Medical Sciences, Niayesh Highway Intersection, Valiasr St. Tehran Tehran Iran (Islamic Republic of)</contact_address>
        <contact_phone></contact_phone>
        <contact_email></contact_email>
      </ethics_review>
    </ethics_reviews>
  </trial>
</trials>
